Kim Moon Ho, Hwang Min Sik, Park Yoon Kyoo, Park Yerim, Ahn Yong Chel, Oh Ho-Suk, Ahn Heui-June
Department of Internal Medicine, Gangneung Asan Medical Center, University of Ulsan College of Medicine, Gangneung, Korea.
Case Rep Oncol. 2015 Jul 30;8(2):295-300. doi: 10.1159/000437295. eCollection 2015 May-Aug.
Guillain-Barré syndrome (GBS) is defined as an acute, autoimmune polyradiculoneuropathy. It is a rare disease that occurs at a rate of 1.11 cases per 100,000 person-years. However, once infected, up to 20%percnt; of patients develop severe disability, and approximately 5%percnt; die. There have been reports of GBS in different cancers. Among them, there are 6 previous reports of GBS in small cell lung cancer. Here, we report a case of a 52-year-old man who was diagnosed with GBS in the setting of small cell lung cancer with chemotherapy.
吉兰-巴雷综合征(GBS)被定义为一种急性自身免疫性多发性神经根神经病。它是一种罕见疾病,发病率为每10万人年1.11例。然而,一旦感染,高达20%的患者会出现严重残疾,约5%的患者会死亡。已有不同癌症中GBS的报道。其中,既往有6例小细胞肺癌患者发生GBS的报道。在此,我们报告一例52岁男性患者,其在接受小细胞肺癌化疗时被诊断为GBS。